Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Biomolecules|January 28, 2026
CILP2: From ECM Component to a Pleiotropic Modulator in Metabolic Dysfunction, Cancer, and BeyondZheqiong Tan, Suotian Liu, Zhongxin LuCell Communication and Signaling : CCS|February 1, 2023
Jak2/STAT6/c-Myc pathway is vital to the pathogenicity of Philadelphia-positive acute lymphoblastic leukemia caused by P190BCR-ABLRun Qin, Teng Wang, Wei He, et al.Clinical Medicine Insights. Oncology|August 6, 2026
Stromal Laminin Subunit Alpha 3 is a Novel Prognostic Marker for Breast CancerZheqiong Tan, Suotian Liu, Dan Zhao, et al.Experimental Hematology & Oncology|May 27, 2022
The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplificationDachuan Zeng, Miao Gao, Renren Zheng, et al.American Journal of Cancer Research|July 15, 2024
mTOR inhibition by AZD2014 alleviates BCR::ABL1 independent imatinib resistance through enhancing autophagy in CML resistant cellsWei He, Suotian Liu, Wei Wei, et al.Cell Communication and Signaling : CCS|June 7, 2024
The FABD domain is critical for the oncogenicity of BCR/ABL in chronic myeloid leukaemiaRenren Zheng, Wei Wei, Suotian Liu, et al.Cancer Cell International|October 22, 2025
PMA exerts anti-leukemia effect in Ph+ ALL through activating PKC δ and its down-stream moleculesXu Wang, Jinfeng Tan, Jie Tang, et al.Pageof 1